The FDA just approved a 'smart' pill that can track if you're taking your medication
The Food and Drug Administration just approved its first-ever pill containing electronic tracking sensors. The anti-psychotic drug Abilify MyCite, which treats bipolar disorder, schizophrenia, and depressive disorders, uses an electronic signal to record whether or not a patient ingested the pill, Gizmodo reported Tuesday.
When it touches stomach acid, the pill generates an electronic signal, which can be used to send data to medical professionals via a smartphone app and a Bluetooth signal. Sending data requires patients to first sign a consent form allowing their data to be shared with their doctors — as well as up to four selected friends and family members — and also wear a patch on their left rib cage that would transmit the information.
The New York Times notes, however, that patients can block data recipients whenever they choose to. That is potentially problematic, Dr. Jeffrey Lieberman, chairman of psychiatry at Columbia University and New York Presbyterian hospital, told the Times: "There's an irony in it being given to people with mental orders that can include delusions. It's like a biomedical Big Brother."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
While patients prone to paranoia may see malicious intent in electronic tracking of drug ingestion, there are significant benefits to being able to track whether or not patients are taking their medication. Studies have shown that people usually take only half of their prescribed doses when they are self-administering medication, and a 2013 study estimated that people not taking their pills properly costs the U.S. between $100 billion and $289 billion a year and leads to 125,000 deaths annually.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Kelly O'Meara Morales is a staff writer at The Week. He graduated from Sarah Lawrence College and studied Middle Eastern history and nonfiction writing amongst other esoteric subjects. When not compulsively checking Twitter, he writes and records music, subsists on tacos, and watches basketball.
-
The potential impact of Trump tariffs for the UK
UK goods exports to the US could be hit with tariffs of up to 20% seriously affecting the British economy
By Sorcha Bradley, The Week UK Published
-
Shoot to Kill: Terror on the Tube – a 'raw' and 'riveting' docuseries
The Week Recommends Channel 4's 'gripping' two-part show explores the Metropolitan police killing of an innocent man in the aftermath of 7/7
By Irenie Forshaw, The Week UK Published
-
'Salute to those who served'
Today's Newspapers A roundup of the headlines from the US front pages
By The Week Staff Published
-
Boeing machinists approve contract, end strike
Speed Read The company's largest union approved the new contract offer, ending a seven-week strike
By Peter Weber, The Week US Published
-
US economy still strong in final preelection report
Speed Read It grew at a solid 2.8% annual rate from July through September
By Peter Weber, The Week US Published
-
Boeing machinists reject deal, continue strike
Speed Read The rejection came the same day Boeing reported a $6.2 billion quarterly loss
By Peter Weber, The Week US Published
-
Ports reopen after dockworkers halt strike
Speed Read The 36 ports that closed this week, from Maine to Texas, will start reopening today
By Peter Weber, The Week US Published
-
Empty-nest boomers aren't selling their big homes
Speed Read Most Americans 60 and older do not intend to move, according to a recent survey
By Peter Weber, The Week US Published
-
Brazil accuses Musk of 'disinformation campaign'
Speed Read A Brazilian Supreme Court judge has opened an inquiry into Elon Musk and X
By Rafi Schwartz, The Week US Published
-
Disney board fends off Peltz infiltration bid
Speed Read Disney CEO Bob Iger has defeated activist investor Nelson Peltz in a contentious proxy battle
By Rafi Schwartz, The Week US Published
-
Disney and DeSantis reach detente
Speed Read The Florida governor and Disney settle a yearslong litigation over control of the tourism district
By Peter Weber, The Week US Published